← Leaderboards
Xiang-An Li
Va Medical Center - Lexington, Ky
$6,083,647
Attributed
$7,599,544
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $902.1K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,599,544 · 4
VA$0 · 2
By mechanism
R01$5,706,178 · 3
R35$1,893,366 · 1
I01$0 · 2
Top collaborators
- Anna Schwendeman5 shared
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingCessation Of LifeKnockout MiceSepsisSepticInflammatoryResponseIn VivoRisk FactorsMediatingSr-Bi ReceptorCytokinePlayBacteriaSeptic ShockHigh Density LipoproteinsAnimalsMacrophageMortalityEffective TherapyInfectionPredispositionPathogenesisPositioning Attribute
Grant awards (27)
Relative adrenal insufficiency as a risk factor and an endotype for sepsis$382,500
R35 · FY2025 · GM · contact PI
Mechanism of the adrenal stress response protection against therapy-induced lethal immune activation$0
I01 · FY2025 · VA · contact PI
Relative adrenal insufficiency as a risk factor and an endotype for sepsis$382,500
R35 · FY2024 · GM · contact PI
Mechanism of the adrenal stress response protection against therapy-induced lethal immune activation$0
I01 · FY2024 · VA · contact PI
Relative adrenal insufficiency as a risk factor and an endotype for sepsis$382,500
R35 · FY2023 · GM · contact PI
HDL as a therapeutic target for sepsis$0
I01 · FY2023 · VA · contact PI
Relative adrenal insufficiency as a risk factor and an endotype for sepsis$382,500
R35 · FY2022 · GM · contact PI
HDL as a therapeutic target for sepsis$0
I01 · FY2022 · VA · contact PI
Relative adrenal insufficiency as a risk factor and an endotype for sepsis$363,366
R35 · FY2021 · GM · contact PI
HDL as a therapeutic target for sepsis$0
I01 · FY2021 · VA · contact PI
Mechanism of adrenal insufficiency as a risk factor for sepsis$293,818
R01 · FY2020 · GM · contact PI
HDL as a therapeutic target for sepsis$0
I01 · FY2020 · VA · contact PI
Synthetic HDL_a potential sepsis therapy$603,893
R01 · FY2019 · GM · contact PI
Mechanism of adrenal insufficiency as a risk factor for sepsis$295,270
R01 · FY2019 · GM · contact PI
Synthetic HDL_a potential sepsis therapy$603,893
R01 · FY2018 · GM · contact PI
Mechanism of adrenal insufficiency as a risk factor for sepsis$298,202
R01 · FY2018 · GM · contact PI
Synthetic HDL_a potential sepsis therapy$603,893
R01 · FY2017 · GM · contact PI
Mechanism of adrenal insufficiency as a risk factor for sepsis$298,202
R01 · FY2017 · GM · contact PI
Synthetic HDL_a potential sepsis therapy$603,893
R01 · FY2016 · GM · contact PI
Synthetic HDL_a potential sepsis therapy$616,222
R01 · FY2015 · GM · contact PI
Role of SR-BI in LPS detoxification$226,147
R01 · FY2012 · GM · contact PI
Role of SR-BI in LPS detoxification$121,464
R01 · FY2012 · GM · contact PI
Role of SR-BI in LPS detoxification$226,147
R01 · FY2011 · GM · contact PI
Role of SR-BI in LPS detoxification$228,431
R01 · FY2010 · GM · contact PI
Role of SR-BI in LPS detoxification$230,738
R01 · FY2009 · GM · contact PI
Role of SR-BI in LPS detoxification$225,227
R01 · FY2009 · GM · contact PI
Role of SR-BI in LPS detoxification$230,738
R01 · FY2008 · GM · contact PI